Stockholders’ Equity (Details) - USD ($)					9 Months Ended	12 Months Ended
	Dec. 31, 2023	Feb. 15, 2023	Dec. 31, 2022	Jan. 05, 2022	Dec. 31, 2021	Dec. 31, 2023	Dec. 31, 2022	Jun. 20, 2023
Stockholders’ Equity (Details) [Line Items]
Net proceeds from common stock issuance						$ 7,222,363	$ 4,505,664
Shares forfeited (in Shares)						2,190	14,297
Share-based compensation expense						$ 1,500,000	$ 400,000
Unamortized share-based compensation expense						$ 4,500,000
Weighted average term						2 years 1 month 6 days
Offering cost								$ 75,000,000
Gross proceeds percentage						3.00%
At-the-Market Offering Program [Member]
Stockholders’ Equity (Details) [Line Items]
Net proceeds from direct offering						$ 1,200,000
Sold an aggregate shares (in Shares)						79,862
2021 Equity Incentive Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Stock issued during period, restricted stock award grants (in Shares)			24,880		98,440	323,452
Issued and outstanding shares percentage	8.50%		8.50%
Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)						79,862	302,800
Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)		395,779
Price per share (in Dollars per share)		$ 15.16
Net proceeds from direct offering		$ 6,000,000
Common Stock [Member] | Over-Allotment Option [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)				302,800
Price per share (in Dollars per share)				$ 16
Additional gross proceeds				$ 4,844,800
Net proceeds from common stock issuance				4,505,664
Underwriting commissions				$ 339,136